Brexpiprazole Tablets bulk supplier for pharma manufacturers

Brexpiprazole Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg

Reference Brands: Rexulti®(US & EU)

Category: Psychiatry / Mental Health

Brexpiprazole is an atypical antipsychotic that acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at 5-HT2A receptors. This balanced activity helps modulate dopamine and serotonin pathways in the brain. It is used for the treatment of schizophrenia and as an adjunctive therapy for major depressive disorder (MDD) in adults, offering improved mood stabilization and reduced psychotic symptoms with a lower risk of extrapyramidal side effects.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Brexpiprazole tablets are FDA-approved in the United States for the treatment of schizophrenia and as an adjunctive therapy for major depressive disorder (MDD) in adults. In the European Union, Brexpiprazole is approved under brand names like Rxulti, primarily for schizophrenia, following centralized EMA procedures. Regulatory compliance includes GMP standards, comprehensive clinical data, and documentation on metabolic side effects, akathisia, and suicidality risks. U.S. submissions must meet FDA requirements including boxed warnings for elderly dementia-related psychosis. EMA approval mandates a full Risk Management Plan (RMP) and pharmacovigilance commitments. For dossier-ready Brexpiprazole tablets and sourcing options, visit Pharmatradz.com — your trusted B2B pharma platform.

Brexpiprazole Tablets — third party manufacturing & bulk supply

Brexpiprazole Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Brexpiprazole Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Brexpiprazole Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Brexpiprazole Tablets →

Back to Listing

Frequently Asked Questions

Brexpiprazole is used to treat psychiatric conditions such as schizophrenia and as an adjunct therapy for major depressive disorder. It helps improve mood, reduce psychotic symptoms, and enhance overall functioning in patients with mental health disorders.

Brexpiprazole is a synthetic pharmaceutical compound that acts as a serotonin–dopamine activity modulator. It is manufactured under controlled pharmaceutical processes to ensure purity, stability, and consistent therapeutic effects.

Brexpiprazole is marketed under the brand name Rexulti in the United States and other regions.

Brexpiprazole (Rexulti) is manufactured and marketed by Otsuka Pharmaceutical Co., Ltd. in partnership with other authorized distributors depending on the region.

The generic name is Brexpiprazole.

The most recognized brand name is Rexulti.

Brexpiprazole is manufactured in regulated pharmaceutical facilities that comply with international quality standards, including sites in the United States, Japan, and other regions where the product is approved for use.